| Mon, Nov 9, 2009 | | • | Status of Pfizer and Wyeth research facilities
AP (Mon 6:23pm)
| | • | Business Highlights
AP (Mon 5:56pm)
| | • | Pfizer cutting R&D at Research Triangle Park, Sanford
at bizjournals.com (Mon 5:05pm)
| | • | Pfizer trimming research plants after buying Wyeth
AP (Mon 5:02pm)
| | • | [video] Sell Pfizer!: Against the Grain
at TheStreet.com (Mon 2:37pm)
| | Fri, Nov 6, 2009 | | • | Biosimilars, Biologics, Biotech And Specialty Pharmaceuticals: Piper Jaffray Picks The Stocks And Sectors With Highest Potential Returns For Investors
Wall Street Transcript (Fri, Nov 6)
| | Thu, Nov 5, 2009 | | • | Moody's upgrades ratings for Wyeth
AP (Thu, Nov 5)
| | • | Placing Bets On Human Genome's Benlysta
Indie Research (Thu, Nov 5)
| | • | Product Envy: What Americans Want But Can't Have
at Minyanville.com (Thu, Nov 5)
| | Wed, Nov 4, 2009 | | • | Merck, now No. 2 drugmaker, set for future buys
AP (Wed, Nov 4)
| | Mon, Nov 2, 2009 | | • | A Cure for Cancer?
at CNBC (Mon, Nov 2)
| | • | New damages trial for Wyeth in Ark. hormones case
AP (Mon, Nov 2)
| | Sun, Nov 1, 2009 | | • | Pfizer backs US health reform
at FT.com (Sun, Nov 1)
| | Thu, Oct 29, 2009 | | • | Merck's buy of Schering-Plough gets FTC approval
AP (Thu, Oct 29)
| | Wed, Oct 28, 2009 | | • | Pfizer giving 2 execs bonuses after Wyeth deal
AP (Wed, Oct 28)
| | Tue, Oct 27, 2009 | | • | Charts And Fundamentals Are A Powerful Pair
at Forbes.com (Tue, Oct 27)
| | • | In Memoriam
at Forbes.com (Tue, Oct 27)
| | Mon, Oct 26, 2009 | | • | Pa. jury returns verdict in Prempro-cancer case
AP (Mon, Oct 26)
| | • | Earnings Preview: GlaxoSmithKline Q3 earns seen up
AP (Mon, Oct 26)
| | Sun, Oct 25, 2009 | | • | J&J wants deals with rivals to share risk
at FT.com (Sun, Oct 25)
|
Add WYE News to My Yahoo!:
 
| |
|
2.03% Nasdaq 0.00%
Headlines
